pliva

  • Roundup: 1st, 3rd, 5th and D.C. Circuits

    Design defect claims against generic drugs not preempted; Employer owns copyright of computer program worker developed at home; Texas cannot defund Planned Parenthood; Citations under OSHA subject to six-month statute of limitations

  • Supreme Court grants victory to generic drug companies

    Chalk one up for the drug companies. In a hotly contested decision, the Supreme Court yesterday ruled in Pliva, Inc. v. Mensing that generic drug companies are immune from consumer lawsuits alleging misleading product labeling.

Advertisement. Closing in 15 seconds.